![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/4985 | |
A61K 31/55 | |||
C07D 471/04 | |||
C07D 471/14 | |||
C07D 491/14 | |||
A61P 31/18 | |||
A61K 45/06 |
(11) | Number of the document | 2986291 |
(13) | Kind of document | T |
(96) | European patent application number | 14785780.9 |
Date of filing the European patent application | 2014-04-11 | |
(97) | Date of publication of the European application | 2016-02-24 |
(45) | Date of publication and mention of the grant of the patent | 2020-05-27 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2014/033720 |
Date | 2014-04-11 |
(87) | Number | WO 2014/172188 |
Date | 2014-10-23 |
(30) | Number | Date | Country code |
201361812489 P | 2013-04-16 | US |
(72) |
GRAHAM, Thomas, H., US
WAI, John, S., US
STAMFORD, Andrew, US
LIU, Wensheng, US
|
(73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
(54) | 4-PYRIDONE DERIVATIVE COMPOUNDS AND USES THEREOF AS HIV INTEGRASE INHIBITORS |
4-PYRIDONE DERIVATIVE COMPOUNDS AND USES THEREOF AS HIV INTEGRASE INHIBITORS |